Stage M2 : LLM-based prediction of metabolite-level drug responses in cancer cell lines from biomedical literature
TrialMatchAI: Harnessing Large Language Models (LLMs) to Match Cancer Patients with Molecularly-driven Clinical Trials – Part of the European Open Science Cloud for Cancer Project